Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.37 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23852496 | 0.80 | TAAR1 (0.39) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL9541239 | 0.79 | TAAR1 (0.42) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL17051292 | 0.79 | PDCD1 (0.37) | TAAR1ALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL20512217 | 0.79 | HSPA5 (0.48) | TAAR1ALDH1A1TSHRLMNAKMT2A | |
| SCHEMBL20746223 | 0.79 | TAAR1 (0.52) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL808983 | 0.78 | TAAR1 (0.45) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL13722854 | 0.78 | TAAR1 (0.45) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL15976426 | 0.78 | TAAR1 (0.45) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL3167835 | 0.78 | RIPK1 (0.48) | TAAR1SSTR4ADRB2ADRB1HPGD | |
| SCHEMBL18325596 | 0.78 | DPP4 (0.41) | TAAR1ALDH1A1TSHRLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122847-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2017-02-01 | — | — | EP | claimed |
| EP-1474095-B2 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2016-12-21 | — | — | EP | claimed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | claimed |
| WO-2015148743-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2015-10-01 | — | — | WO | claimed |
| US-20150275132-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2015-10-01 | — | — | US | claimed |
| EP-1474095-B1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2013-06-12 | — | — | EP | claimed |
| EP-2581077-A2 | Olfactory adaption and cross-adapting agents to reduce the perception of body odors | Symrise AG (DE) | 2013-04-17 | — | — | EP | claimed |
| US-20100254927-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2010-10-07 | — | — | US | claimed |
| US-20070020210-A1 | Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents | MONELL CHEMICAL SENSES CENTER | 2007-01-25 | — | — | US | claimed |
| EP-3521409-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2024-08-14 | — | — | EP | disclosed |
| US-20240225915-A1 | COMPOSITIONS FOR FIGHTING MALODORS | SYMRISE AG (DE) | 2024-07-11 | — | — | US | disclosed |
| EP-4351667-A1 | COMPOSITIONS FOR FIGHTING MALODORS | Symrise AG (DE) | 2024-04-17 | — | — | EP | disclosed |
| WO-2022258189-A1 | COMPOSITIONS FOR FIGHTING MALODORS | SYMRISE AG (DE) | 2022-12-15 | — | — | WO | disclosed |
| EP-3521409-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2019-08-07 | — | — | EP | disclosed |
| US-7763238-B2 | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors | MONELL CHEMICAL SENSES CENTER (US) | 2010-07-27 | — | — | US | disclosed |
| EP-1474095-A4 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2007-11-28 | — | — | EP | disclosed |
| US-20070020210-A1 | Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents | MONELL CHEMICAL SENSES CENTER | 2007-01-25 | — | — | US | disclosed |
| EP-1474095-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2004-11-10 | — | — | EP | disclosed |
| US-20030152538-A1 | Olfactory adaptation and cross-adapting agents to reduce the perception of body odors | SYMRISE INC. | 2003-08-14 | — | — | US | disclosed |
| WO-2003061609-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | TAAR1 615/4885SSTR4 2383/4885ADRB2 438/4885 |
| US-20150275132-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | TAAR1 615/4885SSTR4 2383/4885ADRB2 438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.